Evidence map›Paper›PMID 17349584›Full record

ArticleCancer cell2007

Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

Andrea Vecchione, Gustavo Baldassarre, Hideshi Ishii, Milena S Nicoloso, Barbara Belletti, Fabio Petrocca, Nicola Zanesi, Louise Y Y Fong, Sabrina Battista, Daniela Guarnieri and 5 more

Open access · greenAbstract read
In one paragraph

Article in Cancer cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Fine-tuning neuron number:bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Unveiling the oncogenic role of LZTS1 in colorectal cancer.Journal of cellular and molecular medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.International journal of molecular sciences · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 3 countries.

Andrea VecchioneDepartment of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
Gustavo Baldassarre
Hideshi Ishii
Milena S Nicoloso
Barbara Belletti
Fabio Petrocca
Nicola Zanesi
Louise Y Y Fong
Sabrina Battista
Daniela Guarnieri
Raffaele Baffa
Hansjuerg Alder
John L Farber
Peter J Donovan
Carlo M Croce
The Ohio State University · USCentro di Riferimento Oncologico · ITAzienda Ospedaliera Sant'Andrea · ITFederico II University Hospital · ITInstitute of Polymers, Composites and Biomaterials · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITJichi Medical University · JPJohns Hopkins University · USSidney Kimmel Cancer Center · USThomas Jefferson University · US

Funding

8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CAR01CA083698 · NCI · THOMAS JEFFERSON UNIVERSITY · PI CROCE, CARLO M · 2000 to 2004
$2.1M
NCI NIH HHS R01 CA083698
6 · The paper itself

Abstract

The FEZ1/LZTS1 (LZTS1) protein is frequently downregulated in human cancers of different histotypes. LZTS1 is expressed in normal tissues, and its introduction in cancer cells inhibits cell growth and suppresses tumorigenicity, owing to an accumulation of cells in G2/M. Here, we define its role in cell cycle regulation and tumor progression by generating Lzts1 knockout mice. In Lzts1(-/-) mouse embryo fibroblasts (MEFs), Cdc25C degradation was increased during M phase, resulting in decreased Cdk1 activity. As a consequence, Lzts1(-/-) MEFs showed accelerated mitotic progression, resistance to taxol- and nocodazole-induced M phase arrest, and improper chromosome segregation. Accordingly, Lzts1 deficiency was associated with an increased incidence of both spontaneous and carcinogen-induced cancers in mice.

Indexed as

Cell Transformation, NeoplasticMitosisAnimalsAntineoplastic AgentsCarcinogenscdc25 PhosphatasesCDC2 Protein KinaseCell Cycle ProteinsCell DivisionCells, CulturedChromosome SegregationDimethylnitrosamineFibroblastsMiceMice, KnockoutMolecular Sequence DataAntineoplastic AgentsCarcinogensCDC25C protein, humanCdc25c protein, mousecdc25 PhosphatasesCDC2 Protein KinaseCell Cycle ProteinsDimethylnitrosaminenitrosobenzylmethylamineNocodazolePaclitaxelTumor Suppressor Proteins

Identifiers

PMID17349584
PMCPMC1987708
OpenAlexW2041267432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.